cetylpyridinium chloride anhydrous has been researched along with Berger Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, R; Chatham, WW; Fan, R; Hall, S; Julian, BA; Lee, JY; Mestecky, J; Moldoveanu, Z; Novak, J; Robinson, J; Suzuki, H; Suzuki, Y; Tomana, M; Tomino, Y; Wyatt, RJ; Zhang, Z | 1 |
| Kocsis, B; Kovács, T; Nagy, J; Schmelczer, M; Vas, T; Wagner, L | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Berger Disease
| Article | Year |
|---|---|
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
Topics: Acetylglucosamine; Adult; Amino Acid Sequence; Antibody Specificity; Cell Line; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Health; Humans; Immunoglobulin A; Immunoglobulin G; Molecular Sequence Data | 2009 |
Effect of smoking on urinary NOx and cGMP excretion in IgA nephropathy and in health.
Topics: Adult; Age Factors; Creatine; Cyclic GMP; Female; Glomerulonephritis, IGA; Health; Humans; Male; Nitrites; Smoking | 2000 |